Cancer in the crosshairs

Switzerland has joined an unprecedented scientific collaboration between Europe and the United States to accelerate nanomedicine testing in a bid to conquer a common enemy: cancer.

10.09.2015

Switzerland has joined an unprecedented scientific collaboration between Europe and the United States to accelerate nanomedicine testing in a bid to conquer a common enemy: cancer.

Many of us take medicines’ side effects for granted as the price to pay for getting better. But some side effects, which occur when disease-fighting drugs damage healthy tissues in the cross-fire, may become a thing of the past with the development of nanomedicines.

Nanotechnology is a branch of science that deals with particles less than 100 nanometres (0.00001-centimetres) in size. Applying nanotechnology to medicine makes sense, since the molecular building blocks of the human body, as well as of many viruses and other disease-causing agents, are measured at the nanoscale.

more …

Events where you meet EUNCL

More Events ...

European Nanomedicine Characterisation Laboratory (EUNCL)

Call for Proposals!

News

  • Last General Assembly met in Stoos, Switzerland 23. - 24. May 2019
    The project’s last General Assembly took place under the motto ‘overview, impact and forecast’. The Work Package leader presented a pre-final report on their respective WPs, recapitulating the tasks accomplished during the last 3,5 years of the project’s runtime.
  • NCI-NCL – Open position
    The NCL is looking for an experienced analytical chemist to add to our team.
  • EUNCL ExBo Meeting in Liverpool
    The EUNCL ExBo met on 22nd and 23rd November 2018 at University of Liverpool to discuss the actual status of the work in the project and especially in the TNA. The CET and TNA management updated the ExBo on the on-going and the further work planned. The discussion on all questions raised during the meeting was very extensive and important decisions were taken for the last year of the project duration.

More News ...